NFKB1 and adult T-cell leukemia/lymphoma: On the other hand, ATLL cells frequently lose Tax expression but acquire the ability to activate the canonical NF-κB pathway without Tax through genetic and epigenetic alterations involving the T-cell receptor/NF-κB signaling pathway, miR-31 silencing, and IL-17RB overexpression [16].